Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on PFIZER INC
03:57p PFIZER : Prices $1,065,000,000 Debt Offering
08:20a 11 Key Questions Answered for Rapid, Rigorous and Reproducible Pharmaceutical..
02/24 PFIZER : Prices $1,065,000,000 Debt Offering
02/24 PFIZER INC. (LON : PFZ) Files An 8-K Departure of Directors or Certain Officers;..
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23 PFIZER INC : Financial Statements and Exhibits (form 8-K)
02/23 PFIZER : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
02/23 PFIZER : Ronald E. Blaylock Elected to Pfizer’s Board of Directors
02/23 Spark Therapeutics Reports 2016 Financial Results and Business Highlights
02/23 PFIZER : AIDS ACTION COMMITTEE $200K grant to support Needle Exchange
02/22 MANUFACTURING DELAY OF GENERIC DRUG : PFE) A Relief For Teva Pharmaceutical Ind..
02/22 PFIZER : Viagra maker Pfizer cites poor performance for stock de-listing
02/21 Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/21 PFIZER : Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin..
02/21 HERE’S WHAT THE LATEST PAIN TH : PTIE) Update Means
02/21 PFIZER : The Cancer Drugs Fund
02/20 PFIZER : Celltrion Healthcare & Pfizer’s biosimilar shows positive results..
02/20 PFIZER : New Data in Crohn's Disease Patients Shows Similar Efficacy and Safety ..
02/20 PFIZER : MSF urges SA government & researchers to conduct further research for a..
02/20 PFIZER : MSF urges SA government & researchers to conduct further research for a..
02/20 PFIZER : continues expansion
02/17 PFIZER : New Data in Crohn’s Disease Patients Shows Similar Efficacy and S..
02/17 PFIZER : Announces Top-Line Results from the Oral Strategy Trial of XELJANZ (tof..
02/17 PFIZER : New Data in Crohn's Disease Patients Shows Similar Efficacy and Safety ..
02/16 PFIZER : Announces Top-Line Results from the Oral Strategy Trial of XELJANZ® (to..
02/16 PFIZER : Tabuk Pharma to provide high-value medicines to society
02/16 PFIZER : Announces Top-Line Results from the Oral Strategy Trial of XELJANZ (tof..
02/15 PFIZER : New Collaboration with Pfizer Aimed at Speeding Drug Discovery
02/14 Gilead challenges GSK with strong HIV drug data
02/13 Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
02/13 PFIZER : Panel Discussion Topics Released for Pre- Filled Syringes East Coast 20..
02/13 PFIZER : The Cancer Drugs Fund
02/13 OXFORD BIODYNAMICS : Appoints Former Pfizer Man As Adviser
02/12 PFIZER : Lighting the way for manufacturing
02/11 PFIZER : bounces back from Allergan setback by buying, buying, buying
02/10 PFIZER UK RESPONSE TO BREAST CANCER : 'NICE reject another promising drug - wil..
02/09 PFIZER : Announces Positive Top-Line Results from Phase 2 Study of Investigation..
02/09 PFIZER : Receives Positive CHMP Opinion in Europe for XELJANZ® tofacitinib citra..
02/09 Verastem Announces Dosing of First Patient in Combination Trial of Defactinib..
02/09 PFIZER : Dr Katherine Barclay, Pfizer UK, appointed as board member for the Inst..
02/09 PFIZER : Relationship Expert Teams Up with Pfizer to Address Intimacy and Relati..
02/09 PFIZER : Ophthalmologists, Pfizer Unite to Check Glaucoma Spread in S’ Eas..
02/08 Allergan says U.S. tax reform unlikely in 2017, sees strong year
02/08 PFIZER : Marcher pour sensibiliser à la prévention de la maladie
02/08DJSanofi Net Profit More Than Doubles -- Update
02/08 PFIZER : Democrats Oppose Republican Repeal of Measure Curbing Corporate Tax Avo..
02/07 WORLD SMOKING CESSATION DRUGS MARKET : Pfizer, Imperial Tobacco
02/07 PFIZER : High glaucoma incidence in South East zone worries Pfizer, SEOF
02/07 PFIZER : Governor Announces Grant to Fight Drug Overdose Fatalities
02/06 PFIZER : Breast cancer drug costs too high in relation to benefits for routine N..
02/06 PFIZER INC. : Blog Coverage Pfizer Signs Agreement with Citibank to Repurchase $..
02/03 PFIZER INC’S (NYSE : PFE) Breast Cancer Drug Too Expensive: Says NICE
02/03 PFIZER INC. (LON : PFZ) Files An 8-K Financial Statements and Exhibits
02/03DJPFIZER : Files 8K - Other Events
02/03 PFIZER INC : Other Events, Financial Statements and Exhibits (form 8-K)
02/03 PFIZER : Commences $5 Billion Accelerated Share Repurchase
02/03 PFIZER : breast cancer drug too expensive for NHS
02/03 PFIZER : Invites Public to View and Listen to Webcast of January 31 Conference C..
02/03 PFIZER : UK agency says Pfizer breast cancer drug too expensive
02/02 PFIZER : hires JPMorgan to weigh sale of some drugs - Bloomberg
02/02 AstraZeneca stands by 2023 sales above $40 billion at today's FX
02/02 PFIZER : Staley Capital Advisers Inc Boosts Position by $31,525,823 in Pfizer
02/01 Hutchison China Adds Former Baxalta, Pfizer Director As Non-Executive
02/01DJMore Headaches for Drugmakers -- WSJ
02/01 BECTON DICKINSON AND : Off the Corporate Track
02/01DJTrump's Criticism of Imports Adds to Drugmakers' Headaches -- Update
02/01 PFIZER INC. : ex-dividend day
01/31DJPFIZER : CEO Supports Trump Calls for Lower Pricing, Manufacturing Jobs -- Updat..
01/31DJPFIZER : CEO Supports Trump Calls for Lower Pricing, Manufacturing Jobs
01/31 PFIZER : PFE) Adds on Earnings Projections
01/31 PFIZER : Receives Positive CHMP Opinion in Europe for XELJANZ (tofacitinib citra..
01/31 INDUSTRY EXPERTS SHARE THEIR INSIGHT : Challenges and Solutions – Creating..
01/31DJHot Stocks to Watch in the U.S. and Canada
01/31 PFIZER INC : Results of Operations and Financial Condition, Financial Statements..
01/31DJPFIZER : Revenue Falls; Full-Year Sales Seen Below Wall Street Expectations
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2017 53 326 M
EBIT 2017 20 087 M
Net income 2017 12 686 M
Debt 2017 28 566 M
Yield 2017 3,72%
P/E ratio 2017 15,40
P/E ratio 2018 13,92
EV / Sales 2017 4,36x
EV / Sales 2018 4,08x
Capitalization 203 911 M
More Financials
Chart PFIZER INC
Duration : Period :
Pfizer Inc Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 38,0 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Ole Isacson Chief Scientific Officer
W. Don Cornwell Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC13.96%207 902
JOHNSON & JOHNSON6.53%333 891
ROCHE HOLDING LTD.5.42%210 192
PFIZER INC.5.48%207 902
NOVARTIS AG4.72%202 648
MERCK & CO., INC.12.38%182 412
More Results